Delivery Order SPE2DB22D3401-SPE2DB24FT4PD
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60s medication. The contract, valued at $26,860.44, has an ultimate completion date of August 26, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these prescription drugs to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,702.14, is for the provision of 4,565,699,026 units of the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract is a firm fixed price, has no set-aside designation, and has an ultimate completion date of September 6, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,401.57, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm-fixed price delivery order, with a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,877.88, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,181.40 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This contract is part of a larger...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,880.52, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024 and a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,447.72 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a completion date of February 23, 2024 and was awarded on February 22, 2024. There is no set-aside designation associated with this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,444.07, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of July 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,139.46, is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.26 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...